Ocugen (OCGN) Debt Ratio (2014 - 2026)

Ocugen's (OCGN) quarterly Debt Ratio came in at 0.51 in Q1 2026, up 19.52% YoY from 0.43 in Q1 2025, and down 22.46% on a QoQ basis from 0.66 in Q4 2025.

Ocugen (OCGN) Debt Ratio (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Debt Ratio data on file, last reported at 0.51 in Q1 2026.

  • Quarterly Debt Ratio rose 19.52% year-over-year to 0.51 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.51 (up 19.52% YoY) and the FY2025 annual result came in at 0.66, up 90.25% from the prior year.
  • Debt Ratio fell to 0.51 in Q1 2026, from 0.66 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.66 in Q4 2025 to a low of 0.01 in Q1 2022.
  • A 5-year average of 0.2 and a median of 0.05 in 2024 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio tumbled 73.16% — and 2025, when it surged 957.85%.
  • Tracing OCGN's Debt Ratio over 5 years: stood at 0.02 in 2022, then soared by 105.87% to 0.04 in 2023, then soared by 701.7% to 0.35 in 2024, then jumped by 90.25% to 0.66 in 2025, then retreated by 22.46% to 0.51 in 2026.
  • The last three Debt Ratio figures came in at 0.51 (Q1 2026), 0.66 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Ocugen 457.71 Mn 357.61 Mn - 0.01

Historic Data

Download Data
DateValue
Jun 30, 2026 0.01
Mar 31, 2026 0.51
Dec 31, 2025 0.66
Sep 30, 2025 0.49
Jun 30, 2025 0.52
Mar 31, 2025 0.43
Dec 31, 2024 0.35
Sep 30, 2024 0.05
Jun 30, 2024 0.07
Mar 31, 2024 0.05
Dec 31, 2023 0.04
Sep 30, 2023 0.04
Jun 30, 2023 0.03
Mar 31, 2023 0.02
Dec 31, 2022 0.02
Sep 30, 2022 0.02
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.02
Sep 30, 2021 0.01